TrialClinical genitourinary cancer2020

Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment.

Ravi A Madan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.